Vireo Advisors Coordinating OECD Workshop to Advance Use of Adverse Outcome Pathways (AOP) for Nanomaterial Risk Assessment

Vireo Advisors Coordinating OECD Workshop to Advance Use of Adverse Outcome Pathways (AOP) for Nanomaterial Risk Assessment

Vireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.

Read More

REACH Registration for Graphene and Graphene Oxide achieved by the Graphene REACH Registration Consortium

REACH Registration for Graphene and Graphene Oxide achieved by the Graphene REACH Registration Consortium

The Graphene REACH Registration Consortium, which includes companies such as The Sixth Element Material Technology and Applied Graphene Materials, have registered graphene (CAS 1034343-98-0) and graphene oxide through the European Chemicals Agency (ECHA), allowing for sales up to 10 tons per annum in the European Market.

Read More

US National Nanotechnology Initiative holds Second Quantitative Estimate of Exposure to Nanomaterials Conference (QEEN II) Oct 9-10

US National Nanotechnology Initiative holds Second Quantitative Estimate of Exposure to Nanomaterials Conference (QEEN II) Oct 9-10

Jo Anne Shatkin, as well as new team members Dr. Shaun Clancy, and Cassidy Pomeroy-Carter were part of the planning and coordination of the conference, organizing panel discussions on exposure to nanomaterials in food and food contact items, and stakeholder perspectives, respectively.

Read More